Loading clinical trials...
Loading clinical trials...
Clinical Study on the Safety and Efficacy of CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
Conditions
Interventions
CAR-T Therapy
Locations
1
China
Guangzhou Medical University Affiliated Women and Children's Medical Center
Guangzhou, Guangdong, China
Start Date
October 1, 2024
Primary Completion Date
December 31, 2027
Completion Date
June 30, 2028
Last Updated
December 31, 2024
NCT05376111
NCT04065399
NCT05453500
NCT07295951
NCT05292664
NCT03970096
Lead Sponsor
Guangzhou Women and Children's Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions